Calcium
Calcium from food looks safe for the heart at ordinary intakes, while large pills carry a probable heart-attack signal — and the fracture benefit people take it for is absent in healthy adults and uncertain even in the deficient and care-home elderly. The move is to hit 1,000–1,200 mg/day from food, pair it with vitamin D, vitamin K2, and enough magnesium to route it into bone rather than artery, and supplement only the gap — in small doses, with meals.
More than 99% of the body's calcium sits in bone as a structural mineral. The other 1%, circulating in blood and inside cells, runs an enormous amount of biology: nerve signalling, muscle contraction, blood clotting, hormone release, and gene transcription. That dual role is why calcium intake can't be optimised by simply maximising the number on the label. The skeleton wants enough; the bloodstream and the inside of every cell want it tightly regulated. Get the regulation wrong — usually by taking large isolated supplements — and the same mineral that builds bone starts calcifying arteries and pushing cells toward premature ageing.
The dietary-versus-supplement divide
This is the single most important thing to understand about calcium, and it is counter-intuitive: calcium from food looks safe for the cardiovascular system at ordinary intakes, while calcium from supplements carries a probable risk signal — at the same total intake.
The food side is reassuring rather than proven protective. In a US national survey that followed 6,172 adults (median age 61) for about seven years, people with higher calcium intake had lower death rates overall and from heart disease and cancer, up to a point: the curve was J-shaped, and very high intakes lost the benefit.[1] The same held for calcium from supplements (about 21% lower death risk at 600 mg a day or more, HR 0.79), so this kind of study does not show that food calcium is uniquely protective; it only suggests that adequate intake is not harmful. The clearest illustration is the Multi-Ethnic Study of Atherosclerosis (MESA), which followed 5,448 adults free of cardiovascular disease for a decade: those with the highest total calcium intake had the lowest risk of developing new coronary artery calcification — the calcified plaque that hardens arteries.[2]
The supplement side looks different. When the same MESA analysis isolated supplement use — adjusting for total intake — calcium supplements were independently associated with a 22% higher risk of developing coronary artery calcification.[3] A 2020 meta-analysis that pooled both cohort studies and randomized trials found that, in the trials, calcium supplements raised coronary heart disease risk by about 8% (RR 1.08) and heart-attack risk by about 14% (RR 1.14); in the subgroup of trials that gave calcium without vitamin D, the increases were about 20% and 21% (RR 1.20 and 1.21). In the cohort studies, calcium from food (200–1,500 mg a day) showed no such link.[4] An earlier meta-analysis, of trials giving calcium without vitamin D, put the heart-attack signal at about 31%.[5] A large Swedish cohort complicates the picture rather than supporting it. Following 61,433 women for 19 years, it found the problem was very high calcium intake from food: women eating more than 1,400 mg a day had about 40% higher death rates (HR 1.40) and about 50% higher cardiovascular death rates (HR 1.49) than women eating 600–1,000 mg. The small group who also took calcium tablets on top of such a diet had about 2.6 times the death rate (HR 2.57), but on average, taking calcium tablets was not linked to earlier death.[6]
The evidence is genuinely contested, and honesty requires saying so. A 2021 meta-analysis of 23 randomized trials in about 89,000 community-dwelling adults found no clear effect of vitamin D or calcium supplements on deaths or major cardiovascular events, but nearly all of those people were in trials of vitamin D, alone or with calcium. The six calcium-only trials covered about 3,700 people for deaths (about 5% lower, RR 0.95, not significant), and only three of them, with about 2,200 people, reported major cardiovascular events (about 21% higher, RR 1.21, also not significant) — far too few to rule a harm in or out.[7] The longest hard-outcome readout is the 22-year follow-up of the Women's Health Initiative (WHI) trial (about 36,000 postmenopausal women randomized to 1,000 mg of calcium (as calcium carbonate) plus 400 IU vitamin D3 or placebo for roughly seven years): supplementation was tied to a small reduction in cancer mortality (about 7%) but a small increase in cardiovascular mortality (about 6%), with no effect on all-cause mortality — a trade-off that maps almost exactly onto the food-versus-supplement thesis, though the trial cannot separate calcium's effect from vitamin D's (Moderate).[8] Mendelian-randomization (genetic) studies are split, but not evenly: the most-cited analysis found that a lifelong genetic tendency to higher serum calcium tracks with higher odds of coronary artery disease and heart attack, triangulating the cardiovascular signal.[9] Notably, the same genetic approach finds no skeletal upside — genetically higher serum calcium is not associated with greater bone density or fewer fractures — and broader reviews of these studies confine the causal effects to the heart, not to bone, stroke, cancer, or diabetes.[10][11] Industry-aligned reviewers argue the harm trials had compliance and confounding problems. The fair reading is not "supplements are proven dangerous" but "supplements offer no cardiovascular upside and carry a plausible downside that food does not — so the burden of proof is on supplementing, not on eating calcium-rich food."
Newer large cohorts point to two groups in whom the risk may be concentrated: people with diabetes and people who already have cardiovascular disease. Among 434,374 UK Biobank adults, regular calcium-supplement users with diabetes had about a third higher risk of cardiovascular disease (HR 1.34) and about two-thirds higher risk of dying from it (HR 1.67); users without diabetes showed no extra risk (HR 0.97).[12] Among Hong Kong patients aged 40 and over with diagnosed cardiovascular disease (17,720 prescribed calcium, matched to 17,720 who were not), those on calcium had about 10% more repeat cardiovascular events (HR 1.10). The excess was about 21% with calcium alone (HR 1.21), and there was none when calcium was combined with vitamin D (HR 0.97).[13] Both studies are observational, so they flag who should be most cautious rather than prove harm.
Why the form matters: the bolus effect
The mechanism that reconciles the divide is pharmacokinetic. Food delivers calcium slowly, bound up in protein, fat, and organic acids, so serum calcium barely moves. A supplement delivers 500–1,000 mg of elemental calcium at once, overwhelming the gut's regulated active-transport pathway and flooding the blood by passive diffusion. A single 500–1,000 mg supplement, especially taken on an empty stomach, raises blood calcium to the upper end of the normal range for at least eight hours.[14]
That transient spike may have near-term effects. In one small randomised study of 100 postmenopausal women, a 1,000 mg calcium dose blunted the normal fall in blood pressure over the following hours, leaving systolic pressure more than 5 mmHg higher than with placebo between 2 and 6 hours after the dose. In a subgroup of 40 women, blood started to clot sooner 4 hours after a dose of calcium citrate than after placebo. The authors said these effects need further investigation.[15] Repeated daily, these spikes are the plausible bridge between a calcium pill and the slow accumulation of arterial calcification. Food never produces the spike, which is why dietary calcium and supplemental calcium part ways in the outcome data.
The practical corollaries fall straight out of this: never take more than ~500 mg of elemental calcium at once, always take it with a meal, and prefer a slow-release form if you supplement at all.
How much, and where to get it
The recommended intake is 1,000 mg/day for adults 19–50 (and men to 70), rising to 1,200 mg/day for women over 50 and everyone over 70, because the share of calcium the gut absorbs falls with age, from as much as 60% in infants and young children to about 25% in adults, and lower still in older age.[16] The tolerable upper limit is 2,000–2,500 mg/day. That limit is based on the Women's Health Initiative finding that 1,000 mg a day of supplemental calcium for 7 years went with more kidney stones. High blood calcium is rare in healthy people; when it occurs it is usually caused by a disease such as an overactive parathyroid gland or cancer.[17]
Food sources are not equal, because plant inhibitors (oxalate, phytate) bind calcium in the gut:
| Source | Calcium per serving (approx.) | Bioavailability | Notes |
|---|---|---|---|
| Dairy (yogurt, milk, cheese) | 300–415 mg | ~30% | The reference standard |
| Kale, broccoli, bok choy | Lower absolute | ~27% | Low-oxalate; absorbs nearly as well as dairy |
| Calcium-set tofu, sardines (with bones) | High | High | Excellent non-dairy options |
| Almonds, sesame | Moderate | Moderate | Phytate-limited; soaking helps |
| Spinach | High absolute | ~5% | Oxalate binds almost all of it — a poor calcium source despite the numbers |
The reader-level takeaway: dairy and low-oxalate greens are efficient; spinach is not, regardless of its high label content. A serial National Health and Nutrition Examination Survey (NHANES) analysis (1999–2023) found mean dietary calcium has fallen (about 1,025 → 900 mg/day) while oxalate and phytate intake rose and population hip bone density dropped in parallel — different people at each point, and the authors say only that such diets "may contribute" — so the food-first target is harder to hit than it used to be.[18] Millet, teff, almonds and sesame do better after soaking, sprouting or fermenting. See Bone density.
Does calcium prevent fractures?
This is the reader's first practical question, and the honest answer depends almost entirely on who you are. In healthy community-dwelling adults, calcium — with or without vitamin D — does not measurably prevent fractures. In the very old, vitamin-D-deficient or care-home elderly it may help, but that rests mostly on one early French care-home trial whose result later trials have not repeated. The largest review so far found no difference in effect between trials in high-risk people and trials in everyone else.[19]
The strongest evidence in the general population is null (Strong). A meta-analysis of 33 randomized trials in more than 51,000 community-dwelling adults over 50 found no significant association of calcium, vitamin D, or the two combined with hip fracture or total fractures — and no benefit in any subgroup defined by dose, sex, fracture history, dietary calcium, or baseline vitamin D level.[20] A parallel reading of the bone-density data explains why: increasing calcium intake, from food or supplements, raises bone mineral density by only about 1% — a one-time, non-progressive bump the authors judged "unlikely to lead to a clinically significant reduction in fracture risk."[21]
The possible exception rests largely on one trial (Weak-preliminary for a meaningful benefit). The trial that founded the whole field enrolled 3,270 institutionalised French women, average age 84. Giving them 1,200 mg of elemental calcium plus 800 IU of vitamin D3 daily cut hip fractures by 43% and other nonvertebral fractures by 32% over 18 months among the women who completed it.[22] Over three years of follow-up the effect was smaller: about 23% fewer hip fractures, or about 2.5 fewer per 100 women, in a group whose hip-fracture risk was about 11% over that time. The women were very low in vitamin D (about 20 nmol/L) and ate only about 500 mg of calcium a day, and many may have had undiagnosed bone softening (osteomalacia). The benefit appears tied to that starting deficiency, and later trials have not repeated it.[23]
Pooled analyses do show a small benefit, but most of it comes from that one trial. The largest review so far covered 69 trials and about 154,000 adults, most of them in trials of people living at home. In the 15 trials of calcium plus vitamin D (about 51,000 people), fractures of any kind fell by about 9% (RR 0.91), and in 9 trials hip fractures fell by about 16% (RR 0.84). That is about 1 fracture avoided per 100 people treated and 1 hip fracture per 333, which the authors judged below a clinically meaningful effect. Without the French care-home trial, none of these reductions was statistically clear.[24] An earlier analysis of eight trials, funded by supplement-industry trade groups, reported about 15% fewer fractures overall and 30% fewer hip fractures, but in its own breakdown the total-fracture benefit came from the two care-home trials (about 33% lower risk), with no clear effect in the six trials of people living at home.[25]
Guideline bodies point the same way. The US Preventive Services Task Force recommends against daily supplements of 400 IU or less of vitamin D plus 1,000 mg or less of calcium to prevent fractures in postmenopausal women living at home, and calls the evidence insufficient at higher doses (Moderate).[26] A 2024 draft update, not yet final, goes further: it advises against vitamin D, with or without calcium, to prevent falls or fractures in postmenopausal women and men aged 60 or over who live at home and have no osteoporosis, vitamin D deficiency or previous fracture.[27] The practical rule that falls out: routine calcium supplements do not prevent fractures; in the genuinely deficient or care-home elderly they may help, under medical supervision — which sharpens, rather than contradicts, the food-first message. For bone, the dominant lever is heavy resistance training, not a calcium pill. See Bone density.
The synergistic triad: vitamin D, vitamin K2, and magnesium
Calcium should never be optimised in isolation. Whether absorbed calcium ends up in bone or in arterial walls is decided by three cofactors.
Vitamin D is the gatekeeper for absorption — it is needed for the gut to actively absorb calcium, so a real vitamin D deficiency cuts calcium absorption; it is also required to transcribe osteocalcin, the bone protein that locks calcium into the skeletal matrix. Keep 25-hydroxyvitamin D out of deficiency, roughly 50–125 nmol/L (20–50 ng/mL); no current guideline sets a higher target. See Vitamin D.
Vitamin K2 directs the traffic. Vitamin D builds the calcium-binding proteins, but they are inert until vitamin K2 activates them (by carboxylation). Two matter: osteocalcin pulls calcium into bone, and Matrix Gla Protein sweeps calcium out of arterial walls. Low vitamin K status could leave calcium poorly routed, a proposed contributor to the "double burden" of osteoporosis and hardened arteries.[28] No agreed cut-off for vitamin K status or recommended supplement dose exists yet; small trials have used 90–180 µg/day of K2 (MK-7) alongside vitamin D, but measured only surrogate markers such as artery-wall thickness, not fractures or heart attacks. Fermented foods such as natto and some cheeses supply K2; leafy greens supply K1. If you supplement, MK-7 at 90–180 µg/day, alongside D3. Coordinate with your prescriber if you take warfarin. See Vitamin K2.
Magnesium is calcium's biochemical counterweight. The two compete for the same gut transporters, so a heavy calcium load suppresses magnesium absorption and pushes the body toward relative magnesium depletion. The dietary calcium-to-magnesium ratio may be a useful risk marker, but the evidence is thin (Weak-preliminary). One research group has proposed an optimal window of about 1.7–2.6,[29] and a higher ratio went with a higher estimated 10-year cardiovascular risk score in one 2025 cross-sectional study of employees at an Iranian medical university.[30] A US survey analysis found only that exercise's cancer-mortality benefit appeared in the lower-ratio group, on an interaction test that was not significant,[31] and the often-repeated link between a high ratio and inflammation traces to rat data. The corrective is to keep the ratio within that proposed 1.7–2.6 window; heavy dairy or calcium supplements without enough magnesium-rich greens, nuts, and seeds are the usual way to overshoot it. See Magnesium.
Calcium inside the cell: the longevity-specific angle
Beyond bone and arteries, the deepest connection to ageing happens inside cells. Resting cells keep cytosolic calcium extremely low and release it in brief, precise pulses to signal. Loss of that tight control is a recognised feature of cellular ageing.
In ageing muscle the pumps that clear calcium from the cell's interior (the sarco/endoplasmic reticulum and plasma-membrane calcium pumps) decline, which disturbs calcium balance inside the cell. Senescent cells also release calcium from internal stores through IP3 receptor channels; in lab-grown fibroblasts, switching these channels off let cells escape one form of senescence and delayed another — a cell-culture clue rather than evidence of a single master switch in human ageing.[32] Oxidative stress amplifies the disturbance: it drives calcium transients that trigger the DNA-damage response and lock cells into senescence, while chelating intracellular calcium protects them and stimulates autophagy.[33]
This connects to mitochondria. A modest, regulated flow of calcium into mitochondria (via the mitochondrial calcium uniporter, MCU) is needed to drive energy production — but overload opens the permeability transition pore and triggers cell death. The longevity protein SIRT1 helps gate this; as it declines with age, the gate is left open. Intriguingly, in nematode (C. elegans) lifespan models, slightly restricting calcium entry into mitochondria extends lifespan and preserves late-life mobility — a form of mitohormesis, where mild mitochondrial stress provokes a durable protective response.[34][35]
These are mechanistic and largely preclinical findings, not a basis for any intervention. The honest reading: they explain why whole-body calcium overload is plausibly harmful at the cellular level, and they reinforce that the body's goal for calcium is precise regulation, not maximal quantity. The actionable levers that touch this biology are the ones already on the longevity list — exercise (which raises mitochondrial quality through the same hormetic pathway), not a calcium product.
Two clinical questions worth knowing
Dementia (Weak — not confirmed). A small Swedish observational study once suggested that older women taking calcium supplements developed dementia about twice as often, with a larger signal in women who already had stroke or white-matter damage, but that rested on just 98 supplement users.[36] A randomised trial has since tested it better. Among 1,460 Australian women aged 70 and over given 1,200 mg/day calcium carbonate or placebo for five years and followed for 14.5 years, dementia was not more common on calcium (about 10% lower risk, HR 0.90, a difference compatible with chance). The same held in the small group of 55 women who had already had a stroke.[37] The dementia worry is best treated as unconfirmed.
Parathyroid hormone (PTH) as a biomarker. When calcium and vitamin D status is chronically inadequate, the parathyroid glands raise PTH to pull calcium from bone — and chronically elevated PTH goes with somewhat higher death rates: in a pooled analysis of 10 prospective studies (about 31,600 people), those with the highest PTH had about 19% higher all-cause mortality (RR 1.19), while the link with cardiovascular death was not statistically clear except in men.[38] Among hospitalised internal-medicine patients, elevated PTH carried about 36% higher long-term mortality (HR 1.36).[39] Among Chinese centenarians, the combination of low vitamin D, high PTH, and a high bone-resorption marker carried nearly triple the mortality risk.[40] The lesson is not to chase PTH down with supplements, but that correcting genuine vitamin D and dietary calcium deficiency — which suppresses PTH into the normal range — is the validated win.
Calcium and cancer: a mixed ledger
The cancer evidence cuts both ways, which is worth knowing on a longevity page.
On the protective side, calcium from food looks protective against bowel cancer itself. A UK study followed about 543,000 women for about 17 years. Each extra 300 mg a day of calcium in the diet went with about 17% lower colorectal cancer risk (RR 0.83), and the authors concluded that dairy protects largely through its calcium; the study could not look at supplements.[41] The World Cancer Research Fund rates both calcium-rich foods and calcium supplements as probably lowering bowel cancer risk, but advises against relying on supplements for cancer prevention.[42]
Supplements modestly reduce recurrence of colorectal adenomas — the polyps that precede colorectal cancer. A meta-analysis of randomized trials found about a 13% lower recurrence rate, roughly one avoided recurrence for every 20 people supplemented over three to five years, though the effect on the more dangerous advanced adenomas was not significant (Moderate).[43] The largest and most recent of those trials found no clear benefit: among 2,259 people who had polyps removed, 1,200 mg of calcium a day for 3 to 5 years did not significantly reduce new polyps (RR 0.95, a difference small enough to be chance), and results for advanced polyps were similar.[44] One caution points the other way. In a follow-up of that same trial, there was no effect while people were taking the pills, but 6 to 10 years after starting, people who had taken calcium alone had about 2.7 times the risk of sessile serrated polyps (adjusted risk ratio 2.65), and those who had taken calcium with vitamin D about 3.8 times the risk (3.81). Sessile serrated polyps are a different kind of precancerous polyp. This was a secondary analysis with limited statistical power, so it is a warning sign rather than proof.[45]
On the caution side, higher calcium intake carries a small signal for prostate cancer in men. A large meta-analysis of cohort studies found that each additional 400 mg/day of dietary calcium was associated with about a 5% higher risk of total prostate cancer, and supplemental calcium specifically was linked to a higher risk of fatal prostate cancer (Weak-preliminary).[46] A 2025 update that pooled 21 cohort studies confirmed the link with calcium from food and dairy. Each extra 300 mg a day of calcium from food went with about 6% higher prostate cancer risk, and calcium from dairy with about 5%, while calcium supplements showed no clear link with prostate cancer overall.[47] The World Cancer Research Fund still rates the evidence as less strong than for its main risk factors, saying dairy and calcium "may increase" risk.[48] For men, this is a reason not to push total calcium far above the requirement from any source, including very dairy-heavy diets, not only from supplements.
The kidney-stone paradox
For decades, calcium-stone formers were told to restrict dietary calcium. That was backwards. Adequate dietary calcium binds oxalate in the gut, forming an insoluble complex that leaves in the stool instead of being absorbed and concentrated in the urine — so higher dietary calcium is protective against the most common (calcium-oxalate) stones.[49]
Timing relative to food matters, but it reduces rather than removes the risk. Taking a calcium supplement with meals lowers urinary oxalate and the urine's tendency to form calcium-oxalate crystals; taken at bedtime or between meals it raises urinary calcium without that oxalate benefit, which may raise stone risk.[50] In the small crossover study behind this, urinary calcium rose just as much with either timing. The largest trial points the same way. In the Women's Health Initiative trial, about 36,000 postmenopausal women took 1,000 mg of calcium plus 400 IU of vitamin D a day, or a placebo, for about seven years. The supplement group reported about 17% more urinary-tract stones (HR 1.17): 2.5% versus 2.1%, or roughly 4 extra stones per 1,000 women — even though the tablets were meant to be taken with meals.[51] Stones were self-reported, and the trial cannot tell whether the calcium or the vitamin D caused them. Taking a supplement with food is still sensible, but it does not cancel the extra stone risk; getting calcium from food is the safer route (Moderate).[52]
If you must supplement: choosing a form
Supplements should bridge a documented dietary gap, not act as the primary source. If you supplement, the form changes both absorption and side effects:
| Form | Elemental Ca | Best for | Notes |
|---|---|---|---|
| Citrate | ~21% | Most adults over 50, PPI users, reflux | Absorbed without stomach acid; about a quarter better absorbed than carbonate on an empty stomach, similar with meals |
| Carbonate | ~40% | Budget option, taken with meals | Needs gastric acid; constipation and bloating common; poor on acid-reducers |
| Microcrystalline hydroxyapatite (MCH) | Variable | Mimicking dietary kinetics | Whole-bone-derived; slow, flattened serum rise that avoids the bolus spike; good bone-turnover data |
| Lysinate | Variable | Maximising absorption | Amino-acid-chelated; one trial reported markedly higher bioavailability, but evidence is thin and single-source |
Calcium citrate is the sensible default if you take it between meals or use an acid-reducing drug. It does not need stomach acid, and on an empty stomach it is absorbed about a quarter better than carbonate.[53] Taken with food, the gap largely disappears: in a direct comparison in 37 healthy adults taking each with a light breakfast, carbonate was absorbed just as well.[54] That makes citrate the right choice for anyone on a proton-pump inhibitor and for older adults with low stomach acid. Carbonate's dependence on acid is real but fixable with food: in people without stomach acid it was absorbed about five times less well on an empty stomach, but normally when taken with breakfast,[55] and a week of omeprazole cut fasting absorption in women over 65.[56] Microcrystalline hydroxyapatite is the form most aligned with the bolus-effect logic, since its slow, sustained serum profile avoids the spike while still suppressing bone turnover.[57][58] The headline bioavailability claims for calcium lysinate come from a single industry trial and shouldn't be over-weighted.[59]
A practical calcium protocol
- Target 1,000–1,200 mg/day, food first. Dairy and low-oxalate greens (kale, broccoli, bok choy), calcium-set tofu, and bone-in fish. Don't count spinach.
- Supplement only the gap. Estimate dietary intake; supplement the shortfall, not a flat 1,000 mg on top.
- Never bolus. Cap any single dose at ~500 mg of elemental calcium and split larger needs across the day.
- Always with a meal. It softens the serum spike and binds dietary oxalate, lowering the urine's tendency to form stones, though it does not remove the extra stone risk that supplements carry. The evening meal is a harmless bet: bone breakdown peaks at night on its own internal rhythm,[60] and in one small two-week study, 1,000 mg at 23:00 cut bone-breakdown markers by about 20% while the same dose at 08:00 did nothing measurable.[61]
- Take the triad. Vitamin D3 to keep 25(OH)D at roughly 50–125 nmol/L (20–50 ng/mL), vitamin K2 (MK-7) 90–180 µg/day, and enough magnesium to keep the dietary Ca:Mg ratio within roughly 1.7–2.6.
- Carbonate with a meal works; choose citrate if you take acid-reducers or take calcium between meals, or hydroxyapatite if you want the slowest serum profile.
- For bone, calcium is necessary but not sufficient — the dominant osteogenic stimulus is heavy resistance training. See Bone density.
- Be especially cautious with supplements if you have diabetes or existing cardiovascular disease — that's where the cardiovascular signal concentrates in newer large cohorts. Work with a clinician.
What's overrated
- "More calcium means stronger bones." Above the requirement, extra calcium doesn't add bone — and as a supplement it adds cardiovascular and stone risk. The dose-response flattens; the harm doesn't.
- High-dose calcium monotherapy. A large pill of calcium alone, without vitamin D, K2, and magnesium, is the single configuration the evidence most clearly cautions against.
- Restricting dietary calcium to prevent stones. Backwards — adequate dietary calcium taken with meals is protective.
- Spinach as a calcium source. Oxalate binds almost all of it.
- Coral, oyster-shell, and "whole-food" calcium marketing. No demonstrated advantage over plain citrate, and shell-derived products carry occasional heavy-metal concerns.
For the broader picture of which supplements help, which are gap-fillers, and which cause harm, see Supplements and Supplements to avoid.
Further reading
- Anderson JJB et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification: 10-Year Follow-up of MESA. J Am Heart Assoc 2016.[62]
- Yang C et al. The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease — systematic review and meta-analysis. J Am Coll Nutr 2020.[63]
- Bolland MJ et al. Effect of calcium supplements on risk of myocardial infarction — meta-analysis. BMJ 2010.[64]
- Michaëlsson K et al. Long-term calcium intake and rates of all-cause and cardiovascular mortality. BMJ 2013.[65]
- Zhao J-G et al. Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults. JAMA 2017.[66]
- Chapuy MC et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992.[67]
- Thomson CA et al. Long-Term Effect of Randomization to Calcium and Vitamin D Supplementation on Health in Older Women. Ann Intern Med 2024.[68]
- Larsson SC et al. Association of Genetic Variants Related to Serum Calcium Levels With Coronary Artery Disease and Myocardial Infarction. JAMA 2017.[69]
- Bonovas S et al. Calcium supplementation for the prevention of colorectal adenomas — meta-analysis of randomized controlled trials. World J Gastroenterol 2016.[70]
- Bristow SM et al. Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women. Br J Nutr 2015.[71]
- van Ballegooijen AJ et al. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health. 2017.[72]
- Hibler EA et al. Physical activity, dietary calcium to magnesium intake and mortality in the National Health and Examination Survey 1999-2006 cohort. Int J Cancer 2020.[73]
- Massé O et al. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. BMJ 2026.[74]
- Ghasemifard N et al. Calcium supplementation and the risk of dementia in the Perth Longitudinal Study of Aging Women: a post-hoc analysis of a randomised clinical trial for fracture prevention. Lancet Reg Health West Pac 2025.[75]
- Kern J et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology 2016.[76]
- Late-life survival and mobility via mitohormesis by reducing mitochondrial calcium. 2025.[77]
- Calcium and vitamin D supplementation and kidney stone disease — narrative review. 2021.[78]
- Sakhaee K et al. Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther 1999.[79]
- Recker RR. Calcium absorption and achlorhydria. N Engl J Med 1985.[80]
- NIH Office of Dietary Supplements. Calcium — Health Professional Fact Sheet.[81]